Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 97 clinical trials
featured
RTOG 1115: Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH Agonist and TAK-700 For Men With High Risk Prostate Cancer

RTOG 1115: Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH

  • 74 views
  • 08 Nov, 2020
  • 1 location
featured
A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

  • 196 views
  • 25 Mar, 2021
  • 1 location
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)

sperm injection (ICSI) using a long gonadotropin-releasing hormone (GnRH) agonist protocol versus a short GnRH antagonist protocol.

gonadotropin
follicle stimulating hormone
ovarian stimulation
in vitro fertilization
endometriosis
  • 25 views
  • 09 Jun, 2021
  • 23 locations
Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)

This is a multicenter hospital-based prospective cohort study conducted in institutions with known expertise in performing oocytes/embryo freezing for fertility preservation. The study aims at refining the understanding of the efficacy and safety of controlled ovarian stimulation with or without letrozole in young women with newly diagnosed breast cancer who …

stage iv breast cancer
cancer
letrozole
breast carcinoma
adjuvant chemotherapy
  • 0 views
  • 23 Jan, 2021
  • 4 locations
Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH

Literature suggests that GnRH antagonists are comparatively more often used in cycles which have an unfavorable prior prognosis, and this protocol is an ideal one

gonadotropin
reproductive techniques
ganirelix
hormone antagonist
gonadorelin
  • 22 views
  • 07 Nov, 2020
  • 1 location
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

The purpose of this study is to compare the efficacy of two controlled ovarian stimulation protocols, the GnRH agonist protocol, widely known as the "long" protocol, and the flexible GnRH

ganirelix
triptorelin
ovarian stimulation
estradiol
hormone antagonist
  • 111 views
  • 07 Nov, 2020
  • 1 location
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

Our aim is to access whether we can achieve equivalent pregnancy rates by the addition of six doses of luteal support with recLH after agonist triggering for IVF cycles in the absence of OHSS.

  • 22 views
  • 08 Nov, 2020
  • 1 location
The Effect of Luteal Blood Progesterone Levels on Ongoing Pregnancy Rates

gonadotropin releasing hormone (GnRH) agonist trigger as a luteal phase support (Humaidan, 2010, 2013), the mid luteal P4 levels increased to 77-409 nmol/l and birth rates per transfer raised to %24.

  • 0 views
  • 25 Jan, 2021
  • 2 locations
Protocols of IVF/ICSI in Poor Responders

Comparing two ovarian induction protocols in poor responders in IVF/ICSI cycles

intracytoplasmic sperm injection
  • 0 views
  • 25 Jan, 2021
  • 2 locations
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

The present investigation aims to evaluate the efficacy of an innovative protocol of controlled ovarian stimulation for breast cancer patients, who are candidates for fertility preservation. Currently, vitrification of oocytes and/or embryos after controlled ovarian stimulation is the most established method for female fertility preservation. However, this stimulation induces an …

cancer
follicle stimulating hormone
mastectomy
estrogen
ductal carcinoma
  • 0 views
  • 26 Apr, 2021
  • 1 location